DSpace university logo mark
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > 020 経済学部・経済学研究科 > 020 紀要 > 東南アジア研究年報 > 第47集 >

Firm Strategy and the Asian Advantage : The Case of the Emerging Biotech Industry

ファイル 記述 サイズフォーマット
KJ00004438480.pdf1.41 MBAdobe PDF本文ファイル

タイトル: Firm Strategy and the Asian Advantage : The Case of the Emerging Biotech Industry
著者: Umali, Celia L.
発行日: 2006年 3月24日
引用: 長崎大学東南アジア研究年報. vol.47, p.1-19; 2006
抄録: Asia is considered by many to be the next biotech hub of the world as countries in the region are striving to develop the sector to be the next engine of growth of their respective economies. Recently many pharmacentical firms derive new products from the biotech sector. This paper on one hand examines the strategies pharmaceutical firms adopt to compete in the domestic and global market place and on the other hand evaluates the Asian advantages in terms of market and globalization drivers. Furthermore, we analyze how pharmaceutical firms exploit these Asian advantages as part of their global strategy in pursuit of their profit maximization goal.
キーワード: biotech industry / firm strategy / Asian advantage
URI: http://hdl.handle.net/10069/6791
ISSN: 05471443
資料タイプ: Departmental Bulletin Paper

引用URI : http://hdl.handle.net/10069/6791



Valid XHTML 1.0! Copyright © 2006-2015 長崎大学附属図書館 - お問い合わせ Powerd by DSpace